Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Re-evaluating therapeutic neovascularization.

E D de Muinck1, M Simons

  • 1Section of Cardiology, Department of Medicine, Angiogenesis Research Center, Dartmouth Medical School, Lebanon, NH 03756, USA.

Journal of Molecular and Cellular Cardiology
|January 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Preoperative LVSI assessment in early-stage cervical cancer: Can it reliably guide lymph node management?

Gynecologic oncology·2026
Same author

Thermal asymmetry in the Moon's mantle inferred from monthly tidal response.

Nature·2025
Same author

Author Correction: Syndecan-2 selectively regulates VEGF-induced vascular permeability.

Nature cardiovascular research·2024
Same author

Stability of a Novel PEGylation Site on a Putative Haemoglobin-Based Oxygen Carrier.

Advances in experimental medicine and biology·2022
Same author

Syndecan-2 selectively regulates VEGF-induced vascular permeability.

Nature cardiovascular research·2022
Same author

Reporting guideline for interventional trials of primary and incisional ventral hernia repair.

The British journal of surgery·2021
Same journal

Large extracellular vesicles derived from red blood cells in coronary artery disease patients with anemia promote endothelial dysfunction.

Journal of molecular and cellular cardiology·2026
Same journal

SnRNA-seq identifies FN1-SDC4 axis triggering epicardial activation in right ventricular remodeling in pulmonary hypertension.

Journal of molecular and cellular cardiology·2026
Same journal

Therapeutic impact of normal dietary patterns on diabetic cardiomyopathy: Transcriptomic and proteomic insights.

Journal of molecular and cellular cardiology·2026
Same journal

Structural, biophysical and cellular assessment of filamin C M82K: A test case for VUS interpretation in cardiomyopathy.

Journal of molecular and cellular cardiology·2026
Same journal

Precision modification of heart failure signaling by CRISPR-Cas9 base editing.

Journal of molecular and cellular cardiology·2026
Same journal

Retraction notice to 'Sam68 impedes the recovery of arterial injury by augmenting inflammatory response' [Journal of Molecular and Cellular Cardiology 137 (2019) 82-92].

Journal of molecular and cellular cardiology·2026
See all related articles

Therapeutic neo-vascularization using growth factors has shown promise in animal studies but failed in large clinical trials. Future research should focus on arteriogenesis, the process of new artery formation, for better therapeutic outcomes.

Area of Science:

  • Regenerative Medicine
  • Vascular Biology
  • Clinical Trials

Background:

  • Exogenous growth factors enhance neo-vascularization in animal models.
  • Small clinical studies showed promise, but two large trials yielded negative results.
  • Hypoxia and inflammation are key stimuli for neo-vascularization, involving Hypoxia-Inducible-Factor (HIF-1).

Purpose of the Study:

  • To analyze the reasons for the failure of recent large clinical trials on neo-vascularization.
  • To explore alternative therapeutic strategies for ischemic tissue repair.
  • To investigate the mechanisms of arteriogenesis for future therapeutic development.

Main Methods:

  • Review of existing literature on neo-vascularization and arteriogenesis.
  • Analysis of potential factors contributing to clinical trial failures.

Related Experiment Videos

  • Discussion of mechanistic insights into angiogenesis and arteriogenesis.

    • Main Results:

    • Angiogenesis is primarily hypoxia-dependent, while arteriogenesis is driven by inflammation and hemodynamic factors.
    • Numerous factors, including patient selection, therapy choice, dosing, and trial design, may explain trial failures.
    • Current understanding of arteriogenesis mechanisms is limited compared to angiogenesis.

    Conclusions:

    • The therapeutic focus should shift from angiogenesis to arteriogenesis for ischemic tissue repair.
    • Further research, including genetic studies and population studies, is needed to understand arteriogenesis.
    • Redefining clinical trial endpoints is crucial for advancing therapies for vascularization.